Jenifer Vallejo

knuten till universitetet
Fler filtreringsmöjligheter
  1. 2019
  2. 2018
  3. Antibody-mediated Immunity in Cardiovascular Disease

    Jenifer Vallejo, 2018, Lund: Lund University, Faculty of Medicine. 121 s.

    Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)

  4. Interleukin-25 reduces Th17 cells and inflammatory responses in human peripheral blood mononuclear cells

    Polyxeni T. Mantani, Jenifer Vallejo, Ljungcrantz, I., Jan Nilsson, Harry Björkbacka & Fredrikson, G. N., 2018, I : Human Immunology. 79, 9, s. 685-692

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. 2017
  6. Autoantibodies against aldehyde-modified collagen type IV are associated with risk of development of myocardial infarction

    J. Vallejo, P. Dunér, Fredrikson, G. N., Jan Nilsson & Eva Bengtsson, 2017 dec, I : Journal of Internal Medicine. 282, 6, s. 496-507

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. 2015
  8. Low Levels of IgM Antibodies against an Advanced Glycation Endproduct-Modified Apolipoprotein B100 Peptide Predict Cardiovascular Events in Nondiabetic Subjects.

    Daniel Engelbertsen, Jenifer Vallejo, Quách, T. D., Nordin Fredrikson, G., Alm, R., Bo Hedblad, Harry Björkbacka, Rothstein, T. L., Jan Nilsson & Eva Bengtsson, 2015, I : Journal of Immunology. 195, 7, s. 3020-3025

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift